FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283696266> ?p ?o ?g. }

• W4283696266 endingPage "e0270143" @default.
• W4283696266 startingPage "e0270143" @default.
• W4283696266 abstract "The aim of this study was to compare the clinical outcomes associated with different combinations of oral diabetic drugs among patients with type 2 diabetes mellitus.A prospective multicenter longitudinal, noninterventional observation study design was applied. At baseline (0 month), clinical parameters including glucose profile, renal function, lipid profile and risk assessment for cardiovascular risks were calculated. Mean Weighted difference (MWD) with heterogeneity and effect z was calculated to determine the risk reduction at the end of the study.A total of 1,657 were enrolled to different cohorts with response rate of 75.5%. The distribution of patients was based on prescribed drug. A total of 513 (30.9%) in G1 (metformin alone), 217 (13.09%) in G2 (metformin with Glimepiride), 231 (12.85%) in G3 (Metformin with Gliclazide), 384 (23.17%) in G4 (metformin with Sitagliptin) and 312 (18.89%) in G5 (Metformin with Saxagliptin). There was no significant different in all clinical and social variables at baseline. The Intergroup analysis showed significant differences with all the primary outcome variables except BMI (p = 0.217) and eGFR (p = 0.782) among patients using sulphonylurea (SU) combination (G2 & G3). Findings also showed significant high frequency of emergency visit and hospitalization in G1 (78.16% & 30.8%) as compared to SU (70.1% & 28.3%, p = 0.001) and DPP-4 (56.6% & 20.4%, p = 0.001). The overall reported effect was z = 2.58, p = 0.001 for ASCVD risk reduction assessment.The study concluded that significant effect of Dipeptidyl peptidase-4 inhibitor on reduction of hospitalization, lipid profile and also ASCVD risk score of type-II diabetes mellitus patients regardless of clinical comorbidities. Also, sulfonylurea combinations have showed significant reduction in LDL and triglycerides values." @default.
• W4283696266 created "2022-06-30" @default.
• W4283696266 creator A5016305675 @default.
• W4283696266 creator A5023299936 @default.
• W4283696266 creator A5038910194 @default.
• W4283696266 creator A5054174507 @default.
• W4283696266 creator A5073283596 @default.
• W4283696266 creator A5076755843 @default.
• W4283696266 date "2022-06-28" @default.
• W4283696266 modified "2023-10-01" @default.
• W4283696266 title "Effect of different antidiabetic medications on atherosclerotic cardiovascular disease (ASCVD) risk score among patients with type-2 diabetes mellitus: A multicenter non-interventional observational study" @default.
• W4283696266 cites W1973824615 @default.
• W4283696266 cites W1982202068 @default.
• W4283696266 cites W1997416444 @default.
• W4283696266 cites W2018192866 @default.
• W4283696266 cites W2069645009 @default.
• W4283696266 cites W2094461218 @default.
• W4283696266 cites W2102063342 @default.
• W4283696266 cites W2102511839 @default.
• W4283696266 cites W2168536722 @default.
• W4283696266 cites W2181940024 @default.
• W4283696266 cites W2402936043 @default.
• W4283696266 cites W2460495305 @default.
• W4283696266 cites W2492208984 @default.
• W4283696266 cites W2529195837 @default.
• W4283696266 cites W2567228687 @default.
• W4283696266 cites W2592996796 @default.
• W4283696266 cites W2603386412 @default.
• W4283696266 cites W2607141658 @default.
• W4283696266 cites W2612260840 @default.
• W4283696266 cites W2748197398 @default.
• W4283696266 cites W2786474120 @default.
• W4283696266 cites W2791296143 @default.
• W4283696266 cites W2912681057 @default.
• W4283696266 cites W2913948264 @default.
• W4283696266 cites W2945839164 @default.
• W4283696266 cites W2981702643 @default.
• W4283696266 cites W3000520379 @default.
• W4283696266 cites W3008685714 @default.
• W4283696266 cites W3015680101 @default.
• W4283696266 cites W4212800145 @default.
• W4283696266 cites W652895649 @default.
• W4283696266 doi "https://doi.org/10.1371/journal.pone.0270143" @default.
• W4283696266 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35763504" @default.
• W4283696266 hasPublicationYear "2022" @default.
• W4283696266 type Work @default.
• W4283696266 citedByCount "0" @default.
• W4283696266 crossrefType "journal-article" @default.
• W4283696266 hasAuthorship W4283696266A5016305675 @default.
• W4283696266 hasAuthorship W4283696266A5023299936 @default.
• W4283696266 hasAuthorship W4283696266A5038910194 @default.
• W4283696266 hasAuthorship W4283696266A5054174507 @default.
• W4283696266 hasAuthorship W4283696266A5073283596 @default.
• W4283696266 hasAuthorship W4283696266A5076755843 @default.
• W4283696266 hasBestOaLocation W42836962661 @default.
• W4283696266 hasConcept C126322002 @default.
• W4283696266 hasConcept C134018914 @default.
• W4283696266 hasConcept C23131810 @default.
• W4283696266 hasConcept C2776307423 @default.
• W4283696266 hasConcept C2777180221 @default.
• W4283696266 hasConcept C2778763485 @default.
• W4283696266 hasConcept C2779284873 @default.
• W4283696266 hasConcept C2779306644 @default.
• W4283696266 hasConcept C2780282729 @default.
• W4283696266 hasConcept C2780323712 @default.
• W4283696266 hasConcept C2910068830 @default.
• W4283696266 hasConcept C555293320 @default.
• W4283696266 hasConcept C71924100 @default.
• W4283696266 hasConcept C90924648 @default.
• W4283696266 hasConceptScore W4283696266C126322002 @default.
• W4283696266 hasConceptScore W4283696266C134018914 @default.
• W4283696266 hasConceptScore W4283696266C23131810 @default.
• W4283696266 hasConceptScore W4283696266C2776307423 @default.
• W4283696266 hasConceptScore W4283696266C2777180221 @default.
• W4283696266 hasConceptScore W4283696266C2778763485 @default.
• W4283696266 hasConceptScore W4283696266C2779284873 @default.
• W4283696266 hasConceptScore W4283696266C2779306644 @default.
• W4283696266 hasConceptScore W4283696266C2780282729 @default.
• W4283696266 hasConceptScore W4283696266C2780323712 @default.
• W4283696266 hasConceptScore W4283696266C2910068830 @default.
• W4283696266 hasConceptScore W4283696266C555293320 @default.
• W4283696266 hasConceptScore W4283696266C71924100 @default.
• W4283696266 hasConceptScore W4283696266C90924648 @default.
• W4283696266 hasIssue "6" @default.
• W4283696266 hasLocation W42836962661 @default.
• W4283696266 hasLocation W42836962662 @default.
• W4283696266 hasLocation W42836962663 @default.
• W4283696266 hasLocation W42836962664 @default.
• W4283696266 hasLocation W42836962665 @default.
• W4283696266 hasOpenAccess W4283696266 @default.
• W4283696266 hasPrimaryLocation W42836962661 @default.
• W4283696266 hasRelatedWork W1985523042 @default.
• W4283696266 hasRelatedWork W1991138829 @default.
• W4283696266 hasRelatedWork W2051266868 @default.
• W4283696266 hasRelatedWork W2143633667 @default.
• W4283696266 hasRelatedWork W2172842886 @default.
• W4283696266 hasRelatedWork W2301714968 @default.
• W4283696266 hasRelatedWork W2774449951 @default.

• next